Genomtec Company Description

Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland.

The company’s flagship project is the Genomtec ID, a diagnostic platform that offer mobile genetic diagnosis to patients through streamlined nucleic acid amplification technology (SNAAT) to detect viruses, bacteria, and fungi, as well as genetic mutations by analysis of biological material of patients using swabs, urine, and saliva.

It also develops SNAAT chemistry for mutation detection in oncology. In addition, the company develops and commercializes tests used in the detection of viral infectious diseases and other areas.

Genomtec S.A. was incorporated in 2008 and is based in Wroclaw, Poland.

Genomtec S.A.

Country	Poland
Founded	2008
Industry	Medical Devices
Sector	Healthcare
Employees	26
CEO	Miron Tokarski

Contact Details

Address: Bierutowska Street 57-59 Wroclaw, 51-317 Poland
Phone	48 793 440 931
Website	genomtec.com

Stock Details

Ticker Symbol	GMT
Exchange	Warsaw Stock Exchange
Fiscal Year	January - December
Reporting Currency	PLN
ISIN Number	PLGNMTC00017
SIC Code	2836

Key Executives

Name	Position
Miron Tokarski Ph.D.	Co-Founder, Chief Executive Officer and Member of the Management Board
Michal Wachowski	Chief Financial Officer and Member of the Management Board
Henryk Roguszczak	Co-founder and Chief Designer
Dr. Malgorzata Malodobra-Mazur	Co-founder and Director of Research and Development
Jarek Oleszczuk M.D., Ph.D.	C.B.O